The claim-level records supplied contain zero vitamin D supplementation RCTs with infectious disease outcomes β they cover alopecia, cardiac autonomic function, HVDRR immunity, breast cancer, kidney transplantation, and population deficiency prevalence. A heterogeneity meta-analysis by baseline deficiency subgroups cannot be executed from these data. What the records do support is subgroup-definition context: deficiency is highly prevalent across diverse populations (Karachi 60.2% <20 ng/mL; Tianjin mean 49.44 nmol/L), and seasonality materially shifts baseline status (winter 17.4 vs summer 20.2 ng/mL in transplant recipients), which any subgroup analysis must adjust for . The required missing inputs are: the actual RCT set (e.g., trial-level effect sizes for respiratory/other infections), baseline 25(OH)D strata per arm, and event counts per subgroup.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.